Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: OPERA I

Long-term suppression of MRI disease activity with ocrelizumab

Presented By
Dr Douglas Arnold, McGill University, Canada
Trial
Phase 3, OPERA I/II, ORATORIO
Conference
ECTRIMS 2021

9 December, 2021 14:30

Serum immunoglobulin levels and risk of serious infections

Presented By
Prof. Tobias Derfuss, University Hospital Basel, Switzerland
Conference
ECTRIMS 2019

8 November, 2019 19:23

SHP647 is efficacious and well-tolerated in CD

Trial
OPERA I, OPERA II, TOSCA
Conference
ECCO 2018

28 May, 2018 18:53
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy